Pharmacokinetics derived from PET imaging of inspiring radio-enhancer platinum nanoparticles

Nanomedicine. 2022 Nov:46:102603. doi: 10.1016/j.nano.2022.102603. Epub 2022 Sep 15.

Abstract

Personalized medicine approach in radiotherapy requires the delivery of precise dose to the tumor. The concept is to increase the effectiveness of radiotherapy while sparing the surrounding heathy tissue. This can be achieved by the use of high-Z metal-based nanoparticles (NPs) as radio-enhancers and PET imaging for mapping NPs distribution to guide the irradiation. In the present study, radio-enhancing platinum NPs were radiolabeled and imaged to assess their pharmacokinetics over time. PET imaging of these NPs revealed high enhanced permeation and retention effect. The maximal tumor accumulation (4.8 ± 0.8 %ID/cc) was observed at 24 h post-injection along with persistent accumulation of the NPs, especially at the tumor ring, even after several days. These properties positively suggest the potential clinical use of these NPs.

Keywords: Biodistribution; Pharmacokinetic; Platinum nanoparticles; Positron emission tomography; Radiotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Metal Nanoparticles*
  • Nanoparticles*
  • Neoplasms*
  • Platinum
  • Positron-Emission Tomography / methods
  • Tissue Distribution

Substances

  • Platinum